发明名称 Compositions for regenerating defective or absent myocardium
摘要 Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.
申请公布号 US9327055(B2) 申请公布日期 2016.05.03
申请号 US201414193053 申请日期 2014.02.28
申请人 CORMATRIX CARDIOVASCULAR, INC. 发明人 Matheny Robert G
分类号 A61K38/39;A61K9/00;A61L27/34;A61L27/36;A61L27/54;A61K48/00;A61L27/38;A61K35/38;A61L27/40;A61K38/17;A61K38/18;A61K35/34;A61K35/545;A61K31/726;A61K31/7088;A61K35/37;A61K35/407;A61K35/22;A61L27/58;A61K35/50;A61L27/22 主分类号 A61K38/39
代理机构 Francis Law Group 代理人 Francis Law Group
主权项 1. An injectable graft composition for myocardial tissue regeneration, said composition comprising an acellular extracellular matrix (ECM) from a mammalian tissue source comprising urinary bladder submucosa, said ECM comprising endogenous proteoglycans, transforming growth factor beta (TGF-β) and fibroblast growth factor-2 (FGF-2), said ECM further comprising an exogenously added nucleic acid, said nucleic acid being linked to said ECM, wherein said nucleic acid interacts with said ECM to control matrix formation and remodeling, wherein, when said composition is administered to damaged or diseased cardiovascular tissue, said composition induces stem cell proliferation and differentiation of stem cells into cardiomyocytes.
地址 Roswell GA US